Selected research
Industry Growth & Trends
Global Loratadine Tablets Industry Growth and Trends Forecast to 2032
Market perspective
The global Loratadine Tablets market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.
The North America market for Loratadine Tablets is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.
The Europe market for Loratadine Tablets is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Loratadine Tablets is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global manufacturers of Loratadine Tablets include Anhui Guosen Pharmaceutical Co., Ltd., Beijing Haiwang Zhongxin Pharmaceutical Co., Ltd., Guangdong Hengcheng Pharmaceutical Co., Ltd., Guangxi Nanning Baihui Pharmaceutical Group Co., Ltd., Guangzhou Baiyunshan Tianxin Pharmaceutical Co., Ltd., Heilongjiang Nuojie Pharmaceutical Co., Ltd., Hubei Minkang Pharmaceutical Co., Ltd., Hunan Erkang Pharmaceutical Co., Ltd. and Hunan Zhongnan Pharmaceutical Co., Ltd., among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report provides a structured, data-driven view of the global Loratadine Tablets market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.
The Loratadine Tablets market size, estimates, and forecasts are presented in terms of sales volume (K Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Loratadine Tablets market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Loratadine Tablets.
Key Companies & Market Share Insights
This section analyzes the strategies and performance of leading manufacturers in the global Loratadine Tablets market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.
Loratadine Tablets Market by Company
Anhui Guosen Pharmaceutical Co., Ltd.
Beijing Haiwang Zhongxin Pharmaceutical Co., Ltd.
Guangdong Hengcheng Pharmaceutical Co., Ltd.
Guangxi Nanning Baihui Pharmaceutical Group Co., Ltd.
Guangzhou Baiyunshan Tianxin Pharmaceutical Co., Ltd.
Heilongjiang Nuojie Pharmaceutical Co., Ltd.
Hubei Minkang Pharmaceutical Co., Ltd.
Hunan Erkang Pharmaceutical Co., Ltd.
Hunan Zhongnan Pharmaceutical Co., Ltd.
Jilin Jinheng Pharmaceutical Co., Ltd.
Sancai Shiqi Pharmaceutical Co., Ltd.
Shanxi Qianyuan Pharmaceutical Group Co., Ltd.
Shanxi Xinyu Pharmaceutical Co., Ltd.
Sichuan Deyuan Pharmaceutical Group Co., Ltd.
Sichuan Shenghe Pharmaceutical Co., Ltd.
Tonghua Great Wall Pharmaceutical Co., Ltd.
Yabao Pharmaceutical Group Co., Ltd.
Yunnan Longfa Pharmaceutical Co., Ltd.
Yunpeng Pharmaceutical Group Co., Ltd.
Zhejiang Ruixin Pharmaceutical Co., Ltd.
Zhejiang Asia Pacific Pharmaceutical Co., Ltd.
Loratadine Tablets Segment by Type
20 mg/Tablet
40 mg/Tablet
60 mg/Tablet
Loratadine Tablets Segment by Application
Hospital
Pharmacy
Online e-commerce
Other
Loratadine Tablets Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Colombia
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Loratadine Tablets market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Loratadine Tablets and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Loratadine Tablets.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Loratadine Tablets manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Sales, revenue of Loratadine Tablets in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.
Chapter 13: Concluding Insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- 20 mg/Tablet
- 40 mg/Tablet
- 60 mg/Tablet
Applications
- Hospital
- Pharmacy
- Online e-commerce
- Other
Companies covered
- Anhui Guosen Pharmaceutical Co., Ltd.
- Beijing Haiwang Zhongxin Pharmaceutical Co., Ltd.
- Guangdong Hengcheng Pharmaceutical Co., Ltd.
- Guangxi Nanning Baihui Pharmaceutical Group Co., Ltd.
- Guangzhou Baiyunshan Tianxin Pharmaceutical Co., Ltd.
- Heilongjiang Nuojie Pharmaceutical Co., Ltd.
- Hubei Minkang Pharmaceutical Co., Ltd.
- Hunan Erkang Pharmaceutical Co., Ltd.
- Hunan Zhongnan Pharmaceutical Co., Ltd.
- Jilin Jinheng Pharmaceutical Co., Ltd.
- Sancai Shiqi Pharmaceutical Co., Ltd.
- Shanxi Qianyuan Pharmaceutical Group Co., Ltd.
- Shanxi Xinyu Pharmaceutical Co., Ltd.
- Sichuan Deyuan Pharmaceutical Group Co., Ltd.
- Sichuan Shenghe Pharmaceutical Co., Ltd.
- Tonghua Great Wall Pharmaceutical Co., Ltd.
- Yabao Pharmaceutical Group Co., Ltd.
- Yunnan Longfa Pharmaceutical Co., Ltd.
- Yunpeng Pharmaceutical Group Co., Ltd.
- Zhejiang Ruixin Pharmaceutical Co., Ltd.
- Zhejiang Asia Pacific Pharmaceutical Co., Ltd.
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Market Growth Prospects
- 1.2.1 Global Loratadine Tablets Market Size Estimates and Forecasts (2021-2032)
- 1.2.2 Global Loratadine Tablets Sales Estimates and Forecasts (2021-2032)
- 1.3 Loratadine Tablets Market by Type
- 1.3.1 20 mg/Tablet
- 1.3.2 40 mg/Tablet
- 1.3.3 60 mg/Tablet
- 1.4 Global Loratadine Tablets Market Size by Type
- 1.4.1 Global Loratadine Tablets Market Size Overview by Type (2021-2032)
- 1.4.2 Global Loratadine Tablets Historic Market Size Review by Type (2021-2026)
- 1.4.3 Global Loratadine Tablets Forecasted Market Size by Type (2027-2032)
- 1.5 Key Regions Market Size by Type
- 1.5.1 North America Loratadine Tablets Sales Breakdown by Type (2021-2026)
- 1.5.2 Europe Loratadine Tablets Sales Breakdown by Type (2021-2026)
- 1.5.3 Asia-Pacific Loratadine Tablets Sales Breakdown by Type (2021-2026)
- 1.5.4 South America Loratadine Tablets Sales Breakdown by Type (2021-2026)
- 1.5.5 Middle East and Africa Loratadine Tablets Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
- 2.1 Loratadine Tablets Industry Trends
- 2.2 Loratadine Tablets Industry Drivers
- 2.3 Loratadine Tablets Industry Opportunities and Challenges
- 2.4 Loratadine Tablets Industry Restraints
3 Market Competitive Landscape by Company
- 3.1 Global Top Players by Loratadine Tablets Revenue (2021-2026)
- 3.2 Global Top Players by Loratadine Tablets Sales (2021-2026)
- 3.3 Global Top Players by Loratadine Tablets Price (2021-2026)
- 3.4 Global Loratadine Tablets Industry Company Ranking, 2024 VS 2025 VS 2026
- 3.5 Global Loratadine Tablets Major Company Production Sites & Headquarters
- 3.6 Global Loratadine Tablets Company, Product Type & Application
- 3.7 Global Loratadine Tablets Company Establishment Date
- 3.8 Market Competitive Analysis
- 3.8.1 Global Loratadine Tablets Market CR5 and HHI
- 3.8.2 Global Top 5 and 10 Loratadine Tablets Players Market Share by Revenue in 2025
- 3.8.3 2025 Loratadine Tablets Tier 1, Tier 2, and Tier 3
4 Loratadine Tablets Regional Status and Outlook
- 4.1 Global Loratadine Tablets Market Size and CAGR by Region: 2021 VS 2025 VS 2032
- 4.2 Global Loratadine Tablets Historic Market Size by Region
- 4.2.1 Global Loratadine Tablets Sales in Volume by Region (2021-2026)
- 4.2.2 Global Loratadine Tablets Sales in Value by Region (2021-2026)
- 4.2.3 Global Loratadine Tablets Sales (Volume & Value), Price and Gross Margin (2021-2026)
- 4.3 Global Loratadine Tablets Forecasted Market Size by Region
- 4.3.1 Global Loratadine Tablets Sales in Volume by Region (2027-2032)
- 4.3.2 Global Loratadine Tablets Sales in Value by Region (2027-2032)
- 4.3.3 Global Loratadine Tablets Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Loratadine Tablets by Application
- 5.1 Loratadine Tablets Market by Application
- 5.1.1 Hospital
- 5.1.2 Pharmacy
- 5.1.3 Online e-commerce
- 5.1.4 Other
- 5.2 Global Loratadine Tablets Market Size by Application
- 5.2.1 Global Loratadine Tablets Market Size Overview by Application (2021-2032)
- 5.2.2 Global Loratadine Tablets Historic Market Size Review by Application (2021-2026)
- 5.2.3 Global Loratadine Tablets Forecasted Market Size by Application (2027-2032)
- 5.3 Key Regions Market Size by Application
- 5.3.1 North America Loratadine Tablets Sales Breakdown by Application (2021-2026)
- 5.3.2 Europe Loratadine Tablets Sales Breakdown by Application (2021-2026)
- 5.3.3 Asia-Pacific Loratadine Tablets Sales Breakdown by Application (2021-2026)
- 5.3.4 South America Loratadine Tablets Sales Breakdown by Application (2021-2026)
- 5.3.5 Middle East and Africa Loratadine Tablets Sales Breakdown by Application (2021-2026)
6 Company Profiles
- 6.1 Anhui Guosen Pharmaceutical Co., Ltd.
- 6.1.1 Anhui Guosen Pharmaceutical Co., Ltd. Company Information
- 6.1.2 Anhui Guosen Pharmaceutical Co., Ltd. Business Overview
- 6.1.3 Anhui Guosen Pharmaceutical Co., Ltd. Loratadine Tablets Sales, Revenue and Gross Margin (2021-2026)
- 6.1.4 Anhui Guosen Pharmaceutical Co., Ltd. Loratadine Tablets Product Portfolio
- 6.1.5 Anhui Guosen Pharmaceutical Co., Ltd. Recent Developments
- 6.2 Beijing Haiwang Zhongxin Pharmaceutical Co., Ltd.
- 6.2.1 Beijing Haiwang Zhongxin Pharmaceutical Co., Ltd. Company Information
- 6.2.2 Beijing Haiwang Zhongxin Pharmaceutical Co., Ltd. Business Overview
- 6.2.3 Beijing Haiwang Zhongxin Pharmaceutical Co., Ltd. Loratadine Tablets Sales, Revenue and Gross Margin (2021-2026)
- 6.2.4 Beijing Haiwang Zhongxin Pharmaceutical Co., Ltd. Loratadine Tablets Product Portfolio
- 6.2.5 Beijing Haiwang Zhongxin Pharmaceutical Co., Ltd. Recent Developments
- 6.3 Guangdong Hengcheng Pharmaceutical Co., Ltd.
- 6.3.1 Guangdong Hengcheng Pharmaceutical Co., Ltd. Company Information
- 6.3.2 Guangdong Hengcheng Pharmaceutical Co., Ltd. Business Overview
- 6.3.3 Guangdong Hengcheng Pharmaceutical Co., Ltd. Loratadine Tablets Sales, Revenue and Gross Margin (2021-2026)
- 6.3.4 Guangdong Hengcheng Pharmaceutical Co., Ltd. Loratadine Tablets Product Portfolio
- 6.3.5 Guangdong Hengcheng Pharmaceutical Co., Ltd. Recent Developments
- 6.4 Guangxi Nanning Baihui Pharmaceutical Group Co., Ltd.
- 6.4.1 Guangxi Nanning Baihui Pharmaceutical Group Co., Ltd. Company Information
- 6.4.2 Guangxi Nanning Baihui Pharmaceutical Group Co., Ltd. Business Overview
- 6.4.3 Guangxi Nanning Baihui Pharmaceutical Group Co., Ltd. Loratadine Tablets Sales, Revenue and Gross Margin (2021-2026)
- 6.4.4 Guangxi Nanning Baihui Pharmaceutical Group Co., Ltd. Loratadine Tablets Product Portfolio
- 6.4.5 Guangxi Nanning Baihui Pharmaceutical Group Co., Ltd. Recent Developments
- 6.5 Guangzhou Baiyunshan Tianxin Pharmaceutical Co., Ltd.
- 6.5.1 Guangzhou Baiyunshan Tianxin Pharmaceutical Co., Ltd. Company Information
- 6.5.2 Guangzhou Baiyunshan Tianxin Pharmaceutical Co., Ltd. Business Overview
- 6.5.3 Guangzhou Baiyunshan Tianxin Pharmaceutical Co., Ltd. Loratadine Tablets Sales, Revenue and Gross Margin (2021-2026)
- 6.5.4 Guangzhou Baiyunshan Tianxin Pharmaceutical Co., Ltd. Loratadine Tablets Product Portfolio
- 6.5.5 Guangzhou Baiyunshan Tianxin Pharmaceutical Co., Ltd. Recent Developments
- 6.6 Heilongjiang Nuojie Pharmaceutical Co., Ltd.
- 6.6.1 Heilongjiang Nuojie Pharmaceutical Co., Ltd. Company Information
- 6.6.2 Heilongjiang Nuojie Pharmaceutical Co., Ltd. Business Overview
- 6.6.3 Heilongjiang Nuojie Pharmaceutical Co., Ltd. Loratadine Tablets Sales, Revenue and Gross Margin (2021-2026)
- 6.6.4 Heilongjiang Nuojie Pharmaceutical Co., Ltd. Loratadine Tablets Product Portfolio
- 6.6.5 Heilongjiang Nuojie Pharmaceutical Co., Ltd. Recent Developments
- 6.7 Hubei Minkang Pharmaceutical Co., Ltd.
- 6.7.1 Hubei Minkang Pharmaceutical Co., Ltd. Company Information
- 6.7.2 Hubei Minkang Pharmaceutical Co., Ltd. Business Overview
- 6.7.3 Hubei Minkang Pharmaceutical Co., Ltd. Loratadine Tablets Sales, Revenue and Gross Margin (2021-2026)
- 6.7.4 Hubei Minkang Pharmaceutical Co., Ltd. Loratadine Tablets Product Portfolio
- 6.7.5 Hubei Minkang Pharmaceutical Co., Ltd. Recent Developments
- 6.8 Hunan Erkang Pharmaceutical Co., Ltd.
- 6.8.1 Hunan Erkang Pharmaceutical Co., Ltd. Company Information
- 6.8.2 Hunan Erkang Pharmaceutical Co., Ltd. Business Overview
- 6.8.3 Hunan Erkang Pharmaceutical Co., Ltd. Loratadine Tablets Sales, Revenue and Gross Margin (2021-2026)
- 6.8.4 Hunan Erkang Pharmaceutical Co., Ltd. Loratadine Tablets Product Portfolio
- 6.8.5 Hunan Erkang Pharmaceutical Co., Ltd. Recent Developments
- 6.9 Hunan Zhongnan Pharmaceutical Co., Ltd.
- 6.9.1 Hunan Zhongnan Pharmaceutical Co., Ltd. Company Information
- 6.9.2 Hunan Zhongnan Pharmaceutical Co., Ltd. Business Overview
- 6.9.3 Hunan Zhongnan Pharmaceutical Co., Ltd. Loratadine Tablets Sales, Revenue and Gross Margin (2021-2026)
- 6.9.4 Hunan Zhongnan Pharmaceutical Co., Ltd. Loratadine Tablets Product Portfolio
- 6.9.5 Hunan Zhongnan Pharmaceutical Co., Ltd. Recent Developments
- 6.10 Jilin Jinheng Pharmaceutical Co., Ltd.
- 6.10.1 Jilin Jinheng Pharmaceutical Co., Ltd. Company Information
- 6.10.2 Jilin Jinheng Pharmaceutical Co., Ltd. Business Overview
- 6.10.3 Jilin Jinheng Pharmaceutical Co., Ltd. Loratadine Tablets Sales, Revenue and Gross Margin (2021-2026)
- 6.10.4 Jilin Jinheng Pharmaceutical Co., Ltd. Loratadine Tablets Product Portfolio
- 6.10.5 Jilin Jinheng Pharmaceutical Co., Ltd. Recent Developments
- 6.11 Sancai Shiqi Pharmaceutical Co., Ltd.
- 6.11.1 Sancai Shiqi Pharmaceutical Co., Ltd. Company Information
- 6.11.2 Sancai Shiqi Pharmaceutical Co., Ltd. Business Overview
- 6.11.3 Sancai Shiqi Pharmaceutical Co., Ltd. Loratadine Tablets Sales, Revenue and Gross Margin (2021-2026)
- 6.11.4 Sancai Shiqi Pharmaceutical Co., Ltd. Loratadine Tablets Product Portfolio
- 6.11.5 Sancai Shiqi Pharmaceutical Co., Ltd. Recent Developments
- 6.12 Shanxi Qianyuan Pharmaceutical Group Co., Ltd.
- 6.12.1 Shanxi Qianyuan Pharmaceutical Group Co., Ltd. Company Information
- 6.12.2 Shanxi Qianyuan Pharmaceutical Group Co., Ltd. Business Overview
- 6.12.3 Shanxi Qianyuan Pharmaceutical Group Co., Ltd. Loratadine Tablets Sales, Revenue and Gross Margin (2021-2026)
- 6.12.4 Shanxi Qianyuan Pharmaceutical Group Co., Ltd. Loratadine Tablets Product Portfolio
- 6.12.5 Shanxi Qianyuan Pharmaceutical Group Co., Ltd. Recent Developments
- 6.13 Shanxi Xinyu Pharmaceutical Co., Ltd.
- 6.13.1 Shanxi Xinyu Pharmaceutical Co., Ltd. Company Information
- 6.13.2 Shanxi Xinyu Pharmaceutical Co., Ltd. Business Overview
- 6.13.3 Shanxi Xinyu Pharmaceutical Co., Ltd. Loratadine Tablets Sales, Revenue and Gross Margin (2021-2026)
- 6.13.4 Shanxi Xinyu Pharmaceutical Co., Ltd. Loratadine Tablets Product Portfolio
- 6.13.5 Shanxi Xinyu Pharmaceutical Co., Ltd. Recent Developments
- 6.14 Sichuan Deyuan Pharmaceutical Group Co., Ltd.
- 6.14.1 Sichuan Deyuan Pharmaceutical Group Co., Ltd. Company Information
- 6.14.2 Sichuan Deyuan Pharmaceutical Group Co., Ltd. Business Overview
- 6.14.3 Sichuan Deyuan Pharmaceutical Group Co., Ltd. Loratadine Tablets Sales, Revenue and Gross Margin (2021-2026)
- 6.14.4 Sichuan Deyuan Pharmaceutical Group Co., Ltd. Loratadine Tablets Product Portfolio
- 6.14.5 Sichuan Deyuan Pharmaceutical Group Co., Ltd. Recent Developments
- 6.15 Sichuan Shenghe Pharmaceutical Co., Ltd.
- 6.15.1 Sichuan Shenghe Pharmaceutical Co., Ltd. Company Information
- 6.15.2 Sichuan Shenghe Pharmaceutical Co., Ltd. Business Overview
- 6.15.3 Sichuan Shenghe Pharmaceutical Co., Ltd. Loratadine Tablets Sales, Revenue and Gross Margin (2021-2026)
- 6.15.4 Sichuan Shenghe Pharmaceutical Co., Ltd. Loratadine Tablets Product Portfolio
- 6.15.5 Sichuan Shenghe Pharmaceutical Co., Ltd. Recent Developments
- 6.16 Tonghua Great Wall Pharmaceutical Co., Ltd.
- 6.16.1 Tonghua Great Wall Pharmaceutical Co., Ltd. Company Information
- 6.16.2 Tonghua Great Wall Pharmaceutical Co., Ltd. Business Overview
- 6.16.3 Tonghua Great Wall Pharmaceutical Co., Ltd. Loratadine Tablets Sales, Revenue and Gross Margin (2021-2026)
- 6.16.4 Tonghua Great Wall Pharmaceutical Co., Ltd. Loratadine Tablets Product Portfolio
- 6.16.5 Tonghua Great Wall Pharmaceutical Co., Ltd. Recent Developments
- 6.17 Yabao Pharmaceutical Group Co., Ltd.
- 6.17.1 Yabao Pharmaceutical Group Co., Ltd. Company Information
- 6.17.2 Yabao Pharmaceutical Group Co., Ltd. Business Overview
- 6.17.3 Yabao Pharmaceutical Group Co., Ltd. Loratadine Tablets Sales, Revenue and Gross Margin (2021-2026)
- 6.17.4 Yabao Pharmaceutical Group Co., Ltd. Loratadine Tablets Product Portfolio
- 6.17.5 Yabao Pharmaceutical Group Co., Ltd. Recent Developments
- 6.18 Yunnan Longfa Pharmaceutical Co., Ltd.
- 6.18.1 Yunnan Longfa Pharmaceutical Co., Ltd. Company Information
- 6.18.2 Yunnan Longfa Pharmaceutical Co., Ltd. Business Overview
- 6.18.3 Yunnan Longfa Pharmaceutical Co., Ltd. Loratadine Tablets Sales, Revenue and Gross Margin (2021-2026)
- 6.18.4 Yunnan Longfa Pharmaceutical Co., Ltd. Loratadine Tablets Product Portfolio
- 6.18.5 Yunnan Longfa Pharmaceutical Co., Ltd. Recent Developments
- 6.19 Yunpeng Pharmaceutical Group Co., Ltd.
- 6.19.1 Yunpeng Pharmaceutical Group Co., Ltd. Company Information
- 6.19.2 Yunpeng Pharmaceutical Group Co., Ltd. Business Overview
- 6.19.3 Yunpeng Pharmaceutical Group Co., Ltd. Loratadine Tablets Sales, Revenue and Gross Margin (2021-2026)
- 6.19.4 Yunpeng Pharmaceutical Group Co., Ltd. Loratadine Tablets Product Portfolio
- 6.19.5 Yunpeng Pharmaceutical Group Co., Ltd. Recent Developments
- 6.20 Zhejiang Ruixin Pharmaceutical Co., Ltd.
- 6.20.1 Zhejiang Ruixin Pharmaceutical Co., Ltd. Company Information
- 6.20.2 Zhejiang Ruixin Pharmaceutical Co., Ltd. Business Overview
- 6.20.3 Zhejiang Ruixin Pharmaceutical Co., Ltd. Loratadine Tablets Sales, Revenue and Gross Margin (2021-2026)
- 6.20.4 Zhejiang Ruixin Pharmaceutical Co., Ltd. Loratadine Tablets Product Portfolio
- 6.20.5 Zhejiang Ruixin Pharmaceutical Co., Ltd. Recent Developments
- 6.21 Zhejiang Asia Pacific Pharmaceutical Co., Ltd.
- 6.21.1 Zhejiang Asia Pacific Pharmaceutical Co., Ltd. Company Information
- 6.21.2 Zhejiang Asia Pacific Pharmaceutical Co., Ltd. Business Overview
- 6.21.3 Zhejiang Asia Pacific Pharmaceutical Co., Ltd. Loratadine Tablets Sales, Revenue and Gross Margin (2021-2026)
- 6.21.4 Zhejiang Asia Pacific Pharmaceutical Co., Ltd. Loratadine Tablets Product Portfolio
- 6.21.5 Zhejiang Asia Pacific Pharmaceutical Co., Ltd. Recent Developments
7 North America by Country
- 7.1 North America Loratadine Tablets Sales by Country
- 7.1.1 North America Loratadine Tablets Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.1.2 North America Loratadine Tablets Sales by Country (2021-2026)
- 7.1.3 North America Loratadine Tablets Sales Forecast by Country (2027-2032)
- 7.2 North America Loratadine Tablets Market Size by Country
- 7.2.1 North America Loratadine Tablets Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.2.2 North America Loratadine Tablets Market Size by Country (2021-2026)
- 7.2.3 North America Loratadine Tablets Market Size Forecast by Country (2027-2032)
8 Europe by Country
- 8.1 Europe Loratadine Tablets Sales by Country
- 8.1.1 Europe Loratadine Tablets Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.1.2 Europe Loratadine Tablets Sales by Country (2021-2026)
- 8.1.3 Europe Loratadine Tablets Sales Forecast by Country (2027-2032)
- 8.2 Europe Loratadine Tablets Market Size by Country
- 8.2.1 Europe Loratadine Tablets Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.2.2 Europe Loratadine Tablets Market Size by Country (2021-2026)
- 8.2.3 Europe Loratadine Tablets Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
- 9.1 Asia-Pacific Loratadine Tablets Sales by Country
- 9.1.1 Asia-Pacific Loratadine Tablets Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.1.2 Asia-Pacific Loratadine Tablets Sales by Country (2021-2026)
- 9.1.3 Asia-Pacific Loratadine Tablets Sales Forecast by Country (2027-2032)
- 9.2 Asia-Pacific Loratadine Tablets Market Size by Country
- 9.2.1 Asia-Pacific Loratadine Tablets Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.2.2 Asia-Pacific Loratadine Tablets Market Size by Country (2021-2026)
- 9.2.3 Asia-Pacific Loratadine Tablets Market Size Forecast by Country (2027-2032)
10 South America by Country
- 10.1 South America Loratadine Tablets Sales by Country
- 10.1.1 South America Loratadine Tablets Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.1.2 South America Loratadine Tablets Sales by Country (2021-2026)
- 10.1.3 South America Loratadine Tablets Sales Forecast by Country (2027-2032)
- 10.2 South America Loratadine Tablets Market Size by Country
- 10.2.1 South America Loratadine Tablets Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.2.2 South America Loratadine Tablets Market Size by Country (2021-2026)
- 10.2.3 South America Loratadine Tablets Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
- 11.1 Middle East and Africa Loratadine Tablets Sales by Country
- 11.1.1 Middle East and Africa Loratadine Tablets Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.1.2 Middle East and Africa Loratadine Tablets Sales by Country (2021-2026)
- 11.1.3 Middle East and Africa Loratadine Tablets Sales Forecast by Country (2027-2032)
- 11.2 Middle East and Africa Loratadine Tablets Market Size by Country
- 11.2.1 Middle East and Africa Loratadine Tablets Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.2.2 Middle East and Africa Loratadine Tablets Market Size by Country (2021-2026)
- 11.2.3 Middle East and Africa Loratadine Tablets Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
- 12.1 Loratadine Tablets Value Chain Analysis
- 12.1.1 Loratadine Tablets Key Raw Materials
- 12.1.2 Key Raw Materials Price
- 12.1.3 Raw Materials Key Suppliers
- 12.1.4 Manufacturing Cost Structure
- 12.1.5 Loratadine Tablets Production Mode & Process
- 12.2 Loratadine Tablets Sales Channels Analysis
- 12.2.1 Direct Comparison with Distribution Share
- 12.2.2 Loratadine Tablets Distributors
- 12.2.3 Loratadine Tablets Customers
13 Concluding Insights
14 Appendix
- 14.1 Reasons for Doing This Study
- 14.2 Research Methodology
- 14.3 Research Process
- 14.4 Authors List of This Report
- 14.5 Data Source
- 14.5.1 Secondary Sources
- 14.5.2 Primary Sources
- 14.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst